View Older Stories View More Recent Stories
-
Biote Reports Third Quarter 2025 Financial Results
-
TKO Reports Third Quarter 2025 Results
-
Keros Therapeutics Reports Third Quarter 2025 Financial Results
-
PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2025 RESULTS
-
Wells Fargo CEO expects bank's workforce to shrink further
-
US families turn to food banks and relatives as benefits stall
-
Record Number of UKG Innovation Award Winners Showcase the Power of AI-Led Workforce Transformation
-
Vicarius Joins Pax8 Marketplace to Deliver Vulnerability Remediation to 40,000 MSPs
-
ADP reports 42,000 private jobs added in october, beating estimates
-
PPL Corporation reports third-quarter 2025 results; narrows earnings forecast and reaffirms growth targets
-
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Wall Street ends higher as solid data, strong earnings offset valuation concerns
-
UK services firms report strongest outlook in a year as inflation pressures wane, PMI shows
-
AES Reports Third Quarter 2025 Results
-
MasterBrand Reports Third Quarter 2025 Financial Results
-
Hinge Health reports third quarter 2025 financial results
-
Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2025 Financial Results
-
Broadridge Reports First Quarter Fiscal 2026 Results
-
College Degree, No Job: Unemployment Rate Among Gen Z Grads Up Sharply
-
BTIG Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
-
JELD-WEN cuts 11% of workforce
-
JELD-WEN Reports Third Quarter 2025 Results, Announces Workforce Reductions and Significant Strategic Actions
-
CNO Financial Group Reports Third Quarter 2025 Results
-
TrueBlue Reports Third Quarter 2025 Results
-
SLB launches new AI product as it focuses on digital sales growth
-
VERSES Announces Financing Agreement with a Notional Value of CAD$14 Million and Reduces Staff to Streamline Operations
-
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
-
Iovance reports 26% response rate in lung cancer trial
-
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
-
TScan reaches FDA agreement on pivotal study design for TSC-101
-
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
-
US economy at risk of wobble as lower-income consumers get squeezed
-
Euro zone manufacturing stagnates in October amid weak demand, PMI shows
-
GTT : Q3 2025 Activity Update - Press Release
-
Trump says US, Canada will not restart trade talks
-
Fed's Logan says this week's rate cut was not needed, opposes one in December
-
Fed's Logan says opposed recent rate cut, questions December move
-
69% of consumers failed to reduce their debt last quarter, Achieve survey finds
-
CN Delivers Strong Third Quarter Financial and Operating Results
-
Novo Nordisk CEO says job cuts affecting 9,000 staff almost complete
-
US weekly jobless claims fall, economists estimate
-
DOGE to leave top US markets regulator, sources say
-
Amazon shares soar as cloud growth beats expectations
-
Fortune Brands Innovations Outperforms End Market with Sales Growth in Key Businesses
-
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
-
Judge allows Trump administration to fire most of DOJ race-relations agency's employees
-
H.C. Wainwright Downgrades Sensei Biotherapeutics (SNSE) to Neutral
-
Backblaze and Dimensional Research Reveal Hidden Cost of Cloud Object Storage as Enterprises Confront AI Data Demands
-
Sensei Biotherapeutics discontinues drug development, explores sale
-
The AI hype check: Fortune companies are not hiring AI-ready workers
